State Street’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-334,360
| Closed | -$70.4K | – | 4659 |
|
|
2023
Q2 | $70.4K | Sell |
334,360
-7,700
| -2% | -$1.34K | ﹤0.01% | 4315 |
|
|
2023
Q1 | $54.7K | Hold |
342,060
| – | – | ﹤0.01% | 4482 |
|
|
2022
Q4 | $190K | Hold |
342,060
| – | – | ﹤0.01% | 4120 |
|
|
2022
Q3 | $407K | Buy |
342,060
+23,900
| +8% | +$25.8K | ﹤0.01% | 3857 |
|
|
2022
Q2 | $201K | Sell |
318,160
-1,566,819
| -83% | -$1.2M | ﹤0.01% | 4198 |
|
|
2022
Q1 | $2.15M | Buy |
1,884,979
+86,006
| +5% | +$103K | ﹤0.01% | 3537 |
|
|
2021
Q4 | $4.05M | Buy |
1,798,973
+91,752
| +5% | +$230K | ﹤0.01% | 3345 |
|
|
2021
Q3 | $5.84M | Buy |
1,707,221
+316,522
| +23% | +$976K | ﹤0.01% | 3150 |
|
|
2021
Q2 | $4.16M | Buy |
1,390,699
+1,333,110
| +2,315% | +$4.22M | ﹤0.01% | 3333 |
|
|
2021
Q1 | $186K | Buy |
57,589
+2,300
| +4% | +$7.67K | ﹤0.01% | 3853 |
|
|
2020
Q4 | $117K | Hold |
55,289
| – | – | ﹤0.01% | 3800 |
|
|
2020
Q3 | $65K | Hold |
55,289
| – | – | ﹤0.01% | 3738 |
|
|
2020
Q2 | $50K | Hold |
55,289
| – | – | ﹤0.01% | 3710 |
|
|
2020
Q1 | $46K | Hold |
55,289
| – | – | ﹤0.01% | 3657 |
|
|
2019
Q4 | $53K | Hold |
55,289
| – | – | ﹤0.01% | 3721 |
|
|
2019
Q3 | $57K | Hold |
55,289
| – | – | ﹤0.01% | 3711 |
|
|
2019
Q2 | $100K | Hold |
55,289
| – | – | ﹤0.01% | 3671 |
|
|
2019
Q1 | $104K | Hold |
55,289
| – | – | ﹤0.01% | 3635 |
|
|
2018
Q4 | $65K | Hold |
55,289
| – | – | ﹤0.01% | 3667 |
|
|
2018
Q3 | $150K | Sell |
55,289
-4,316
| -7% | -$8.93K | ﹤0.01% | 3621 |
|
|
2018
Q2 | $114K | Hold |
59,605
| – | – | ﹤0.01% | 3620 |
|
|
2018
Q1 | $125K | Hold |
59,605
| – | – | ﹤0.01% | 3597 |
|
|
2017
Q4 | $121K | Sell |
59,605
-7,800
| -12% | -$16.2K | ﹤0.01% | 3597 |
|
|
2017
Q3 | $89K | Sell |
67,405
-299,771
| -82% | -$372K | ﹤0.01% | 3640 |
|
|
2017
Q2 | $574K | Sell |
367,176
-748,941
| -67% | -$1.44M | ﹤0.01% | 3408 |
|
|
2017
Q1 | $3.6M | Buy |
1,116,117
+127,057
| +13% | +$313K | ﹤0.01% | 2859 |
|
|
2016
Q4 | $1.33M | Sell |
989,060
-42,317
| -4% | -$55.3K | ﹤0.01% | 3223 |
|
|
2016
Q3 | $1.61M | Buy |
1,031,377
+5,063
| +0.5% | +$7.78K | ﹤0.01% | 3058 |
|
|
2016
Q2 | $1.37M | Buy |
1,026,314
+158,687
| +18% | +$742K | ﹤0.01% | 3179 |
|
|
2016
Q1 | $4.57M | Sell |
867,627
-1,222,526
| -58% | -$7.48M | ﹤0.01% | 2595 |
|
|
2015
Q4 | $16.4M | Sell |
2,090,153
-1,641,479
| -44% | -$14.1M | ﹤0.01% | 1861 |
|
|
2015
Q3 | $31.5M | Buy |
3,731,632
+475,929
| +15% | +$4.39M | ﹤0.01% | 1437 |
|
|
2015
Q2 | $35.6M | Buy |
3,255,703
+906,073
| +39% | +$11.6M | ﹤0.01% | 1466 |
|
|
2015
Q1 | $32.8M | Buy |
2,349,630
+620,624
| +36% | +$9.49M | ﹤0.01% | 1483 |
|
|
2014
Q4 | $29.2M | Buy |
1,729,006
+22
| +0% | +$320 | ﹤0.01% | 1522 |
|
|
2014
Q3 | $23.2M | Sell |
1,728,984
-238,910
| -12% | -$2.85M | ﹤0.01% | 1629 |
|
|
2014
Q2 | $25.1M | Sell |
1,967,894
-124,055
| -6% | -$1.29M | ﹤0.01% | 1658 |
|
|
2014
Q1 | $24.9M | Buy |
2,091,949
+169,329
| +9% | +$2.27M | ﹤0.01% | 1611 |
|
|
2013
Q4 | $26.5M | Buy |
1,922,620
+209,276
| +12% | +$2.96M | ﹤0.01% | 1556 |
|
|
2013
Q3 | $29.9M | Sell |
1,713,344
-47,143
| -3% | -$903K | ﹤0.01% | 1449 |
|
|
2013
Q2 | $28.6M | Buy |
+1,760,487
| New | +$54.5M | ﹤0.01% | 1417 |
|
Other funds holding INFI
State Street's INFI Position: Q3 2023 in Review
State Street sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 334,360 shares — an estimated $70.4K sold.
State Street first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $35.6M in Q2 2015. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- State Street reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- State Street sold 334,360 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $70.4K.
- State Street first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- State Street's Infinity Pharmaceuticals, Inc. position peaked at $35.6M in Q2 2015.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.